Biktarvy

Biktarvy, a combination of Bictegravir, Emtricitabine, and Tenofovir Alafenamide, is a medication used to treat HIV-1 infection in adults and pediatric patients who weigh at least 14 kg. It's a complete regimen for the treatment of this condition and is intended for patients with no antiretroviral treatment history or for those who are virologically suppressed on a stable antiretroviral regimen.

Dosage:

• Adults and pediatric patients weighing 25 kg or more: One tablet of 50 mg Bictegravir/200 mg Emtricitabine/25 mg Tenofovir Alafenamide daily, with or without food.
• If a dose is missed, take it as soon as possible unless it's almost time for the next dose. Do not double up on doses.

Side Effects:

• Common side effects include diarrhea, nausea, and headache.
• Serious side effects can include allergic reactions, kidney problems, changes in the immune system, severe liver problems, and too much lactic acid in your blood. It's important to contact your healthcare provider if you experience any symptoms related to these conditions.

Precautions and Interactions:

• Biktarvy is not recommended for patients with severe renal or hepatic impairment.
• It should not be co-administered with dofetilide or rifampin.
• Other medications can interact with Biktarvy, so it's crucial to inform your healthcare provider about all medicines you are taking, including over-the-counter and herbal products.

Storage:

• Store the tablets in their original bottle or blister pack at room temperature, away from moisture and heat.

As for the pricing in Canada, it's known that prescription drugs can sometimes be cheaper in Canada compared to other countries. However, specific pricing information for Biktarvy in Canada would need to be obtained from Canadian pharmacies. Contact us for more information.

Biktarvy should be taken daily, with or without food.